| Arain, Sarina (PreSens Precision Sensing GmbH 200704 RnD Dept) |
n. a. |
PreSens Precision Sensing GmbH |
Germany |
| Araya Callis, Carolina (Bruker 201912 Marketing Luxendo Business) |
General Manager (management) |
Bruker (Group) |
Germany |
| Arbogast, Susanne (Roche 201308 Head Innovation + External Affairs at Roche Diagnostics) |
Business Development Manager / Strategy Manager |
Roche (Group) |
United States (USA) |
| Arciero, Michael (ERS Genomics 202009– VP IP + Commercial Development before USC Stevents Center for Innovation) |
IP Manager |
University of Southern California (USC) |
United States (USA) |
| Arechiga, Adrian (AstraZeneca 201809 Media Contact at Definiens AG) |
Public Relations Manager / Investor Relations Manager |
AstraZeneca (Group) |
Germany |
| Aregger, Melanie (Avelo 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Avelo AG |
Switzerland |
| Arigoni, Markus (Micro-Macinazione 201708 CEO) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
| Arkinstall, Steve (Kymab 201406– CSO before Merck Serono + Glaxo Wellcome) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Armbruster, Franz Paul (Armbruster Biotechnology GmbH 200810) |
n. a. |
Immundiagnostik (Group) |
Germany |
| Armen, Garo H. (Agenus 201402 CEO) |
Chief Executive Officer (CEO) |
Agenus (Group) |
United States (USA) |
| Armstrong, Robert (Rob) (Boston Pharmaceuticals 201511– CEO before Eli Lilly + Amgen |
Chief Executive Officer (CEO) |
BERTARELLI Group (family of Ernesto Bertarelli) |
United States (USA) |
| Arndt, Michaela (Heidelberg ImmunoTherapeutics GmbH 201601– Managing Director before NCT Heidelberg) |
Managing Director |
Heidelberg ImmunoTherapeutics GmbH |
Germany |
| Arnold, Drew (Cartagenia 201203– VP Sales + BusDev North America before GenomeQuest/Gene-IT + Lion Bioscience) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Arnold, Georg (Gene Center Munich 1993) |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Arnold, Jonathan (Qiagen 202409 VP + Head of Translation Science + Precision Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Arnold, Lauren (MacDougall Biomedical Communications 201801) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Arnold, Matthias (DASGIP AG 201201 CEO) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
United States (USA) |
| Aron, Julien (Peak Scientific 201304– Territory Manager for France, Spain, Italy + Portugal) |
Regional manager |
Peak Scientific (Group) |
United Kingdom (GB) |
| Arslan, Aysu (Bio Inx 202412 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bio Inx B.V. |
Belgium |
| Arth, Hans-Lothar (ABK Patent and Trademark Attorneys before Axxima) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Germany |
| Artusio, Lionel (Z Impact Ventures 202407 General Partner) |
General Partner (venture partner) |
Z Impact Ventures (d/b/a Zebra Impact Ventures) |
Switzerland |
| Artuso, Anthony (Merck (DE) 201310 VP Strategy + Business Development at EMD Millipore) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Asadi, Narges Bani (Bina Technologies 201412 CEO + Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Asadullah, Khusru (Bayer 200906 Head Target Discovery) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Asali, Omar (Ranpak 202110 CEO) |
Chief Executive Officer (CEO) |
Ranpak (US) |
United States (USA) |
| Asam, Alexander (HBM Partners 201304 Investment Advisor before Kaneas Capital 2006– founder before DVC) |
Investment Manager |
HBM (Group) |
Switzerland |
| Asam, Dominik (Infineon Technologies 200501) |
n. a. |
Infineon (Group) |
Germany |
| Asano, Marie (European Circular Bioeconomy Fund 202111 Princiap before HTGF 201902 Investment Manager) |
Principal (venture capital) |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
| Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) |
President/Director/Head Business Group/Unit/Division |
Otsuka (Group) |
United States (USA) |
| Ascione, Roberto (Eversana 202410 President Health Innovation before Healthware Group) |
President/Director/Head Business Group/Unit/Division |
Eversana (Group) |
United States (USA) |
| Asferg, Lars O. (Lallemand 202311 President Bio-ingredients) |
President/Director/Head Business Group/Unit/Division |
Lallemand (Group) |
Canada |
| Ash, Nicholas Watson (Nick) (Source Bioscience 200812 Managing Director) |
Managing Director |
Source BioScience (Group) |
United Kingdom (GB) |
| Ashton, Mark (Evotec 200910 EVP Business Development) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Ashton, Paul (Inflammasome Therapeutics 201909 CEO) |
Chief Executive Officer (CEO) |
Inflammasome Therapeutics (US) |
United States (USA) |
| Askeland, Georgina (Hadean Ventures 202407 Senior Associate) |
Associate (venture capital) |
Hadean Ventures AS |
Norway |
| Asokan, Aravind (Univ of North Carolina at Chapel Hill 201704 + StrideBio Co-Founder) |
Researcher (university / research institute) |
University of North Carolina |
United States (USA) |
| Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme) |
President/Director/Head Business Group/Unit/Division |
LabCorp (Group) |
United States (USA) |
| Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics) |
Chief Executive Officer (CEO) |
Congenica (Group) |
United Kingdom (GB) |
| Atkinson, Blair (MacDougall Biomedical Communications 201504) |
Public Relations Manager / Investor Relations Manager |
MacDougall Biomedical Communications Inc. (MBI) |
Germany |
| Atlas, Roee (Lonza 201710– Manager of Collaborative Innovation Center in Israel) |
management (personnel) |
Lonza (Group) |
Israel |
| Atrzadeh, Faranak (Curetis 201904 SVP Scientific Affairs + Marketing) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Netherlands |
| Attinger, Per-Olof (Roche 199201– Head of Coporate Communication) |
communication policy |
Roche (Group) |
Switzerland |
| Aubry, Xavier (Da Vinci Labs 2021– CEO + Founder) |
Chief Executive Officer (CEO) |
Da Vinci Labs SAS |
France |
| Audoly, Laurent (Parthenon Therapeutics 201909– CEO + Co-Founder before Kymera Therapeutics + Pierre Fabre + Pieris) |
Chief Executive Officer (CEO) |
Parthenon Therapeutics (US) |
United States (USA) |
| Auerbach, Günter (Bene-Arzneimittel GmbH 201307– Managing Director before Antisense Pharma + Bayer AG) |
Managing Director |
Bene-Arzneimittel GmbH |
Germany |
| Auf der Maur, Greta (AKos GmbH 201102 Managing Director) |
Managing Director |
AKos Consulting & Solutions Deutschland GmbH (AKos GmbH) |
Germany |
| Aufderheide, Michaela (Cultex Laboratories GmbH 201105 Managing Director + co-founder) |
Managing Director |
Cultex Laboratories GmbH |
Germany |
| Augé, Pascale (INSERM 201403– CEO of Inserm Transfert before Institut Pasteur + Neurotech + Entomed + AB Science) |
Chief Executive Officer (CEO) |
France (govt) |
France |
| Augello, Frank A. |
n. a. |
Qiagen (Group) |
Switzerland |
| Augerson, Sean (Qiagen 201404 VP Supply Chain – Strategic Partner Management) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
| Augsburger, Marc (CURML-UTCF 201005 Operational Manager) |
n. a. |
University of Lausanne (UNIL) |
Switzerland |
| Augustin, Jens (Fraunhofer 201210 Head of Press + Public Affairs Fraunhofer IZI) |
n. a. |
Fraunhofer (Group) |
Germany |
| Augustin, Marc (PolyPeptide 2024Q1– CFO before Lonza + Smith & Nephew Orthopaedics + Alcoa Extrusion + Thyssen Krupp) |
Chief Financial Officer (CFO) |
PolyPeptide (Group) |
Switzerland |
| Aurentz, Vincent (Merck Serono 200809– Executive VP Portfolio Managem + Business Developm) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) |
Principal (venture capital) |
Illumina (Group) |
United States (USA) |
| Avagyan, Lilit (Knauer 202012 Business Development Manager) |
Business Development Manager / Strategy Manager |
Knauer (Group) |
Germany |
| Avenard, Gilles (Acticor Biotech 201612 CEO) |
Chief Executive Officer (CEO) |
Acticor Biotech (Group) |
France |
| Avery, Michelle (Tome Biosciences 202312 VP Corporate Affairs formerly MacDougall Biomedical Communications 201504) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Awada, A. (Institut Jules Bordet 201105 Investigator) |
Researcher (university / research institute) |
Institut Jules Bordet |
Belgium |
| Awenius, Marc (VDI 202303 Head of Office of Bioökonomierat at VDI Technologiezentrum) |
n. a. |
VDI (Verein Deutscher Ingenieure e. V.) |
Germany |
| Ax, Oliver (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
| Axelson, Dodi (Danaher 202210 Head of Communciations at Cytiva) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
United Kingdom (GB) |
| Axon, Steven (Steve) (Glycomine 202207– CEO before Prothelia + Apellis Pharmaceuticals + Merck KGaA) |
Chief Executive Officer (CEO) |
Glycomine Inc. |
United States (USA) |
| Aygen, Sitke (INFAI GmbH 201309 Managing Director) |
Managing Director |
INFAI Institut für biomedizinische Analytic und NMR Imaging GmbH |
Germany |
| Aygün, Hüseyin (BioSpring GmbH 201205 Managing Director) |
Managing Director |
BioSpring (Group) |
Germany |
| Ayyoubi, Silvia (Roche 200803–201603 Head of Global Human Resources + Member of Corp Executive Committe RETIRED 3/16) |
Human Resources Manager |
Roche (Group) |
Switzerland |
| Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| Aziz, Kabeer (Adjuvant Capital 202105) |
Investment Manager |
Adjuvant Capital LLC |
United States (USA) |
| Azoulay, Sam (Roivant 201910 CMO at Roivant Pharma) |
Chief Medical Officer (CMO) |
Roivant (Group) |
United Kingdom (GB) |
| Azzaoui, Kamal (Saverna Therapeutics 2017– CEO + Co-Founder before Novartis) |
Chief Executive Officer (CEO) |
Saverna Therapeutics AG |
Switzerland |
| Baag, Rima |
n. a. |
Danaher (Group) |
Switzerland |
| Baare, Johanna (Traceless Materials 202309 COO + Co-Founder) |
Chief Operating Officer (COO) |
Traceless Materials GmbH |
Germany |
| Baars, Jan (Dolosys GmbH 201305 Managing Director) |
Managing Director |
Dolosys GmbH |
Germany |
| Baaske, Philipp (NanoTemper 201410 Managing Director + Co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Baatz, Martin (Definiens 201104 VP Marketing) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
Germany |
| Babbush, Ryan (Alphabet 202101 Head of Quantum Algorithms at Google Quantum AI) |
n. a. |
Alphabet (formerly Google) (Group) |
United States (USA) |
| Babe, Greg (Bayer Corp 200807– CEO before CEO Bayer MaterialScience) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) |
Chief Executive Officer (CEO) |
Gotham Therapeutics (Group) |
United States (USA) |
| Bach, Alfred (Axaron/Sygnis 200511–201010 CEO resigned 10/10 before BASF + Genentech) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
| Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) |
Managing Partner (investment firm) |
+ND Capital (f.k.a. NanoDimension) |
Switzerland |
| Bach, Juri (High-Tech Gründerfonds 202001 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bach, Susanne (Eucodis Bioscience GmbH 201604 Key Account Manager) |
Sales Manager / Marketing Manager |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Bache, Nicolai (Evosep 201803 Head of Applications) |
Technical Manager |
Evosep ApS |
Denmark |
| Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
France |
| Bacher, Johannes (Curetis 201804 COO before Managing Director + Co-Founder) |
Chief Operating Officer (COO) |
OpGen (Group) |
Germany |
| Bachmair, Christof (Wacker Chemie 202102 Media Realtions + Information) |
Public Relations Manager / Investor Relations Manager |
Wacker (Group) |
Germany |
| Bachmann, Thomas (Eppendorf 201508–201911 CEO before Pesident of Bruker BioSpin Group + Tecan CEO LEFT 12/19) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Backhaus, Dirk (Bayer 202308 Head of Product Supply at Crop Science) |
n. a. |
Bayer (Group) |
Germany |
| Backheuer, Axel (5 Prime GmbH 201105 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
| Backman, Hadassah ( 202107– CEO + Founder of Guardoc Health) |
Chief Executive Officer (CEO) |
Complihealth Ltd. (d/b/a Guardoc Health) |
Israel |
| Bader, Augustinus (Univ Leipzig 201305 Prof for Applied Stem Cell Biology + Cell Technology) |
Professor |
University of Leipzig |
Germany |
| Bader, Manuela (Probiodrug 201711 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Vivoryon (Group) |
Germany |
| Badiani, Kamal (Pepceuticals 202309 Managing Director) |
Managing Director |
Biosynth (since 9/22) (Group) |
United Kingdom (GB) |
| Baechler, Guido (Mainz Biomed 202111 CEO before Singulex 201305– CEO before SVP Operations before Roche Dx) |
Chief Executive Officer (CEO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
| Baehny, Albert M. (Lonza 202005 Board Chairman + interim CEO) |
Board member, non-executive |
Lonza (Group) |
Switzerland |
| Baena, Jesús (Novartis 202002 Director Business Development) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Baerlocher, Urs (Novartis –200708) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Baertschi, Gabriel (Grünenthal 201610– CEO before President AstraZeneca Japan + Managing Director AstraZeneca GmbH) |
Chief Executive Officer (CEO) |
Grünenthal (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
